✦ LIBER ✦

Early-onset Alzheimer's disease: An analysis of CT findings

✍ Scribed by Dr Burton P. Drayer; Albert Heyman; William Wilkinson; Lynn Barrett; Tina Weinberg

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 405 KB
Volume: 17
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410170420

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dementia and myoclonus: Differential dia

Dementia and myoclonus: Differential diagnosis of early-onset alzheimer's disease

✍ Samuel F. Berkovic; Michel Meianson; Frederick Andermann 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

Increasing attention has been paid to the prominence of myoclonus in Alzheimer's disease of early onset. This was particularly striking in many family members affected by autosomal dominant Alzheimer's disease linked to chromosome 14, as recently reported by Haltia and colleagues { 11 and by Lampe a

Age of onset in familial early onset Alz

Age of onset in familial early onset Alzheimer's disease correlates with genetic aetiology

✍ Mullan, Michael ;Houlden, Henry ;Crawford, Fiona ;Kennedy, Angus ;Rogues, Penelo 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

Apolipoprotein E genotypes and age of on

Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease

✍ Ephrat Levy-Lahad; Amnon Lahad; Ellen M. Wijsman; Thomas D. Bird; Dr Gerard D. S 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 2 views

## Abstract The effect of the apolipoprotein E (APOE) ϵ4 allele on age of onset was analyzed in two groups of families with early‐onset Alzheimer's disease (AD), (1) Volga German (VG) kindreds, in which AD is caused by an unknown locus and (2) early‐onset non‐VG families showing evidence of linkage

Evidence for three loci modifying age-at

Evidence for three loci modifying age-at-onset of Alzheimer's disease in early-onset PSEN2 families

✍ Elizabeth E. Marchani; Thomas D. Bird; Ellen J. Steinbart; Elisabeth Rosenthal; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 2 views

Apolipoprotein E ε2 does not increase ri

Apolipoprotein E ε2 does not increase risk of early-onset sporadic Alzheimer's disease

✍ W. K. Scott; A. M. Saunders; P. C. Gaskell; P. A. Locke; J. H. Growdon; L. A. Fa 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB

We examined the association of apolipoprotein E (ApoE) genotype and the risk of early-onset Alzheimer's disease (AD) in 209 white early-onset sporadic cases (43% male) and 303 white controls (48% male) of similar age distribution. The risk of AD was significantly increased, relative to the 313 genot

Analysis of longitudinal data in an Alzh

Analysis of longitudinal data in an Alzheimer's disease clinical trial

✍ Ronald G. Thomas; Julie D. Berg; Mary Sano; Leon Thal 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

Evidence of delayed progression is the primary mechanism for demonstrating therapeutic e cacy in clinical trials in Alzheimer's disease. In the major trials of therapeutic treatment of AD, to date, measures based on clinical judgement and cognitive performance, instead of mortality, have been used a